This inventor holds 3 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 12,268 
3 out of 387 
Years Active: 2021
Title: Johanna Anlahr: Innovator in Medicinal Chemistry
Introduction
Johanna Anlahr is a prominent inventor based in Dortmund, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for the treatment of various diseases. With a total of three patents to her name, her work focuses on innovative solutions for respiratory and inflammatory disorders.
Latest Patents
Anlahr's latest patents include "Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitors." This application relates to novel imidazopyridinyl- or imidazopyrimidinyl-substituted, bridged 1,4-diazepane derivatives. These compounds are designed for the treatment and prevention of diseases, particularly respiratory disorders such as obstructive sleep apneas and snoring. Another significant patent is for "Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereof." This application focuses on novel substituted derivatives aimed at treating fibrotic and inflammatory disorders.
Career Highlights
Throughout her career, Johanna Anlahr has worked with leading pharmaceutical companies, including Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft. Her experience in these organizations has allowed her to develop and refine her innovative ideas into practical applications.
Collaborations
Anlahr has
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile